抗毒明目汤治疗单纯疱疹病毒性角膜炎临床效果观察
|
摘要
目的分析单纯疱疹病毒性角膜炎应用抗毒明目汤治疗的临床效果。方法 38例单纯疱疹病毒性角膜炎患者作为研究对象,按随机分配原则分为参考组与实验组,各19例。参考组患者采用常规西医治疗,实验组患者在对照组基础上采用抗毒明目汤进行治疗,对两组患者的临床疗效进行比较。结果实验组患者总有效率为94.74%,明显高于参考组的68.42%,差异具有统计学意义(P<0.05)。结论对单纯疱疹病毒性角膜炎应用抗毒明目汤治疗能够有效改善患者的不良症状,提高临床疗效,值得推广。
Objective To analyze the clinical effect of Anti-toxin-Ming-mu Decoction in the treatment of herpes simplex keratitis. Methods A total of 38 patients with herpes simplex keratitis were selected as research objects and divided into reference group and experimental group according to principle of random distribution, 19 cases in each group. The reference group was treated with conventional Western medicine treatment, the experimental group was treated with Anti-toxin-Ming-mu Decoction on the basis of reference group. The clinical curative effect of two groups was compared. Results The total effective rate of experimental group was 94.74%, which was significantly higher than 68.42% of reference group, the difference was statistically significant(P<0.05).Conclusion The treatment of herpes simplex keratitis with Anti-toxin-Ming-mu Decoction can effectively improve the adverse symptoms of the patients and improve the clinical efficacy, is worth popularizing.
Objective To analyze the clinical effect of Anti-toxin-Ming-mu Decoction in the treatment of herpes simplex keratitis. Methods A total of 38 patients with herpes simplex keratitis were selected as research objects and divided into reference group and experimental group according to principle of random distribution, 19 cases in each group. The reference group was treated with conventional Western medicine treatment, the experimental group was treated with Anti-toxin-Ming-mu Decoction on the basis of reference group. The clinical curative effect of two groups was compared. Results The total effective rate of experimental group was 94.74%, which was significantly higher than 68.42% of reference group, the difference was statistically significant(P<0.05).Conclusion The treatment of herpes simplex keratitis with Anti-toxin-Ming-mu Decoction can effectively improve the adverse symptoms of the patients and improve the clinical efficacy, is worth popularizing.
引文
[1]熊静,龙辉,周利.祛风明目汤联合雾化熏眼治疗单纯疱疹病毒性角膜炎30例(31眼)疗效观察.湖南中医杂志,2017,33(10):83-85.
[2]欧阳忠,梁燕,赵文君,等.炎琥宁联合更昔洛韦治疗单纯疱疹病毒性角膜炎的临床治疗效果观察.医学综述,2015(10):1912-1913.
[3]陈子燕,李庆生.中药联合无环鸟苷治疗单纯疱疹病毒性角膜炎的临床疗效分析.世界中医药,2017,12(4):825-828.
[4]毕云,王永红,吴鸣宇.抗病毒软胶囊辅助阿昔洛韦治疗单纯疱疹病毒性角膜炎临床分析.检验医学与临床,2016,13(11):1509-1511.
[5]薛红权.更昔洛韦眼用凝胶联合小剂量糖皮质激素治疗单纯疱疹病毒性角膜炎的疗效观察.临床合理用药杂志,2016,9(25):94-95.
[6]莫惠明.炎琥宁联合阿昔洛韦治疗单纯疱疹病毒性角膜炎的临床观察.深圳中西医结合杂志,2016,26(1):136-137.
[7]耿俊梅.探讨清肝明目汤结合西医抗病毒治疗单纯疱疹病毒性角膜炎的疗效.中西医结合心血管病电子杂志,2016,4(13):191-192.
[8]黄俊珺,董学梅.益气养血祛风法治疗复发性单纯疱疹病毒性角膜炎的临床观察.国际眼科杂志,2017,17(12):2318-2320.
[9]王昕华.更昔洛韦对单纯疱疹病毒性角膜炎患者血清及泪液相关指标的影响.海南医学院学报,2016,22(3):300-302,305.
[10]李斌,曾佐德,刘瑛.干扰素联合更昔洛韦眼用凝胶治疗单纯疱疹病毒性角膜炎的临床疗效及安全性评价.国际病毒学杂志,2015,22(4):264-267.
[11]张霞.祛风法在单纯疱疹病毒性角膜炎中的应用.泸州医学院,2014.
[12]唐勇华,李淑琳,韦丽娇.从正虚辨证治疗单纯疱疹病毒性角膜炎体会.新中医,2015(11):259-260.
[13]施丽.龙胆泻肝汤加减治疗单纯疱疹病毒性角膜炎临床观察.医药前沿,2017,7(26):339-340.
[14]刘枚芳,连宝涛,李佩珊,等.三仁汤治疗单纯疱疹病毒性角膜炎验案二则.中国民族民间医药,2016,25(1):47.
[15]王斌,吕颂谊.龙胆泻肝汤治疗肝火炽盛型聚星障30例观察.浙江中医杂志,2015,50(1):33.
[2]欧阳忠,梁燕,赵文君,等.炎琥宁联合更昔洛韦治疗单纯疱疹病毒性角膜炎的临床治疗效果观察.医学综述,2015(10):1912-1913.
[3]陈子燕,李庆生.中药联合无环鸟苷治疗单纯疱疹病毒性角膜炎的临床疗效分析.世界中医药,2017,12(4):825-828.
[4]毕云,王永红,吴鸣宇.抗病毒软胶囊辅助阿昔洛韦治疗单纯疱疹病毒性角膜炎临床分析.检验医学与临床,2016,13(11):1509-1511.
[5]薛红权.更昔洛韦眼用凝胶联合小剂量糖皮质激素治疗单纯疱疹病毒性角膜炎的疗效观察.临床合理用药杂志,2016,9(25):94-95.
[6]莫惠明.炎琥宁联合阿昔洛韦治疗单纯疱疹病毒性角膜炎的临床观察.深圳中西医结合杂志,2016,26(1):136-137.
[7]耿俊梅.探讨清肝明目汤结合西医抗病毒治疗单纯疱疹病毒性角膜炎的疗效.中西医结合心血管病电子杂志,2016,4(13):191-192.
[8]黄俊珺,董学梅.益气养血祛风法治疗复发性单纯疱疹病毒性角膜炎的临床观察.国际眼科杂志,2017,17(12):2318-2320.
[9]王昕华.更昔洛韦对单纯疱疹病毒性角膜炎患者血清及泪液相关指标的影响.海南医学院学报,2016,22(3):300-302,305.
[10]李斌,曾佐德,刘瑛.干扰素联合更昔洛韦眼用凝胶治疗单纯疱疹病毒性角膜炎的临床疗效及安全性评价.国际病毒学杂志,2015,22(4):264-267.
[11]张霞.祛风法在单纯疱疹病毒性角膜炎中的应用.泸州医学院,2014.
[12]唐勇华,李淑琳,韦丽娇.从正虚辨证治疗单纯疱疹病毒性角膜炎体会.新中医,2015(11):259-260.
[13]施丽.龙胆泻肝汤加减治疗单纯疱疹病毒性角膜炎临床观察.医药前沿,2017,7(26):339-340.
[14]刘枚芳,连宝涛,李佩珊,等.三仁汤治疗单纯疱疹病毒性角膜炎验案二则.中国民族民间医药,2016,25(1):47.
[15]王斌,吕颂谊.龙胆泻肝汤治疗肝火炽盛型聚星障30例观察.浙江中医杂志,2015,50(1):33.